title: Cyclophosphamide for CLL: to be or not CYP2B activated?
authors.affiliation: RIGSHOSPITALET.
authors.forename: Christian H
authors.initials: CH
authors.lastname: Geisler
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D065702:Cytochrome P-450 CYP2B6; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D003520:Cyclophosphamide; D001189:Aryl Hydrocarbon Hydroxylases; C585599:CYP2B6 protein, human; D065702:Cytochrome P-450 CYP2B6; D014740:Vidarabine; C024352:fludarabine